Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 17 open reading frame 100 (C17orf100) refers to a protein-coding gene whose product is currently classified as an "uncharacterized protein." The gene is located on human chromosome 17 and encodes a protein with no established molecular function or biological role to date; its protein product has been confirmed but lacks annotations for involvement in distinct cellular or disease processes. C17orf100 is listed in gene and protein databases, but there are no known molecular interactions, disease associations, or validated functions that qualify it as a receptor, enzyme, transporter, or recognized drug target[2]. It is also not referenced in the literature as a biomarker or target for any existing drug or therapy. The information available is primarily limited to gene structure, sequence, and basic protein predictions. The overall assessment is that C17orf100 is a correctly annotated, protein-coding gene with unknown biological function, not used as a therapeutic target or biomarker at present[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 17 open reading frame 100 (C17orf100).